
Brazil: Aché Laboratórios EBITDA 2015-2019
In 2019, the Brazilian pharmaceutical company Aché Laboratórios Farmacêuticos S.A. generated earnings before interests, taxes, depreciation, and amortization (EBITDA) of approximately 1,083 million Brazilian reals. This represents an increase of around 15.4 percent in comparison to the previous year, when the company's EBITDA added up to 939.2 million reals.